China Universal Asset Management »

Mineralys Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $130k 11k 12.31
2024-09-30 $116k 9.6k 12.11
2024-06-30 $68k 5.8k 11.70
2024-03-31 $102k 7.9k 12.91
2023-12-31 $41k 4.8k 8.60

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics